{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:31:27Z","timestamp":1762101087360},"reference-count":61,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1516,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The retinoids, natural and synthetic derivatives of vitamin A, are active in cancer therapy and prevention. Their biological effects are mediated through ligand\u2010dependent interactions with retinoid receptors that associate with specific co\u2010regulators. A better understanding of retinoid chemopreventive mechanisms is needed. Our prior work revealed that all\u2010<jats:italic>trans<\/jats:italic>\u2010retinoic acid (RA) prevented tobacco\u2010specific carcinogenic transformation of cultured human bronchial epithelial cells. RA signaled G1 arrest that permitted repair of genomic DNA damage caused by these carcinogens. RA triggered G1 arrest at least partly through proteasome\u2010dependent degradation of cyclin D1. Proteasomal inhibitors blocked RA\u2010mediated cyclin D1 degradation. To confirm that a specific proteolysis pathway was induced by RA\u2010treatment, a degradation assay was established using <jats:italic>in vitro<\/jats:italic> translated cyclin D1 and cellular extracts from RA\u2010treated or untreated human bronchial epithelial cells. Incubation of RA\u2010treated but not the control cellular extracts with <jats:italic>in vitro<\/jats:italic> translated cyclin D1 led to cyclin degradation. This degradation depended on the PEST domain of cyclin D1, implicating ubiquitination in this retinoid degradation. Retinoid receptor selective agonists demonstrated that retinoic acid receptor (RAR)\u03b2 and retinoid X receptor (RXR) but not RAR\u03b1\u2010 or RAR\u03b3\u2010dependent pathways signaled this cyclin degradation. Findings were extended to the NT2\/D1 human embryonal carcinoma differentiation model where a similar pathway was activated by RA\u2010treatment. To determine whether G1 cyclins were involved directly in bronchial preneoplasia, immunohistochemical expression profiles for cyclins D1 and E were examined. Aberrant expression of these cyclins was frequent in bronchial preneoplasia. Taken together, these findings indicate that ubiquitin\u2010dependent proteolysis of G1 cyclins is a retinoid chemoprevention mechanism. Whether the retinoids represent the optimal agents to activate this pathway is the subject of ongoing work. These findings provide a rationale for combining the retinoids in chemoprevention trials with other agents that do not activate this proteolysis pathway. What is now known about the retinoids as cancer prevention agents will be reviewed. Emphasis is placed on retinoid effects on cell cycle progression at G1.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb02724.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T23:45:29Z","timestamp":1279669529000},"page":"13-22","source":"Crossref","is-referenced-by-count":29,"title":["Cyclin Proteolysis as a Retinoid Cancer Prevention Mechanism"],"prefix":"10.1111","volume":"952","author":[{"given":"KONSTANTIN H.","family":"DRAGNEV","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SARAH J.","family":"FREEMANTLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHAEL J.","family":"SPINELLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ETHAN","family":"DMITROVSKY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1332","article-title":"Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)","volume":"35","author":"Sporn M.B.","year":"1976","journal-title":"Fed. Proc."},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","unstructured":"Nason\u2010Burchenal K. & E. Dmitrovsky. 1999. The retinoids: cancer therapy and prevention mechanisms.InRetinoids. The Biochemical and Molecular Basis of Vitamin A and Retinoid Action (Handbook of Experimental Pharmacology 139:301\u2010322). H. Nau & W. Blaner Eds. Springer. Berlin.","DOI":"10.1007\/978-3-642-58483-1_10"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5340.1073"},{"key":"e_1_2_7_6_2","unstructured":"Hong W.K. & L.M. Itri. 1994. Retinoids and human cancer.InThe Retinoids: Biology Chemistry and Medicine 2nd edit. M.B. Sporn A.B. Roberts & D.S. Goodman Eds.: 597\u2010630. Raven Press Ltd. New York."},{"key":"e_1_2_7_7_2","unstructured":"Gudas L.J. M.B. Sporn & A.B. Roberts. 1994. Cellular biology and biochemistry of retinoids.InThe Retinoids: Biology Chemistry and Medicine 2nd edit. M.B. Sporn A.B. Roberts & D.S. Goodman Eds.: 443\u2010520. Raven Press Ltd. New York."},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","unstructured":"Hong W.K. J. Endicott L. Itri et al.1986. 13\u2010cis\u2010retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315:1501\u20101505.","DOI":"10.1056\/NEJM198612113152401"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.7.539"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806233182501"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199009203231205"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.7.1216"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606133342402"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.21.1847"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404143301501"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605023341801"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605023341802"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.42.6.753"},{"key":"e_1_2_7_19_2","unstructured":"Moon R.C. R.G. Mehta & K.V.N. Rao. 1994. Retinoids and cancer in experimental animals.InThe Retinoids: Biology Chemistry and Medicine 2nd edit. M.B. Sporn A.B. Roberts & D.S. Goodman Eds.: 573\u2010595. Raven Press Ltd. New York."},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.5-5-361"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.10.9.8801176"},{"key":"e_1_2_7_22_2","unstructured":"Mangelsdorf D. K. Umesono & R.M. Evans. 1994. The retinoid receptors.InThe Retinoids: Biology Chemistry and Medicine 2nd edit. M.B. Sporn A.B. Roberts & D.S. Goodman Eds.: 319\u2010349. Raven Press Ltd. New York."},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(97)80066-X"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","unstructured":"A unified nomenclature system for the nuclear receptor superfamily [letter]. 1999. Cell97:161\u2010163.","DOI":"10.1016\/S0092-8674(00)80726-6"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/330444a0"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/332850a0"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.14.5310"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/330624a0"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/345224a0"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90478-U"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.21.8289"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.6.3.329"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.20.9601"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.2.843"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.17.6.3013"},{"key":"e_1_2_7_36_2","first-page":"4804","article-title":"Identification of retinoids with nuclear receptor subtype\u2010selective activities","volume":"51","author":"Lehmann J.M.","year":"1991","journal-title":"Cancer Res."},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1335166"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505253322103"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.7.2694"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90479-V"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/355359a0"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/372107a0"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202981"},{"key":"e_1_2_7_44_2","first-page":"6036","article-title":"N\u2010(4\u2010hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid","volume":"53","author":"Delia D.","year":"1993","journal-title":"Cancer Res."},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.16.1191"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.5.943"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/355446a0"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/358587a0"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/383099a0"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/377454a0"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.22.12070"},{"key":"e_1_2_7_52_2","first-page":"1983","article-title":"Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down\u2010regulation","volume":"13","author":"Langenfeld J.","year":"1996","journal-title":"Oncogene"},{"key":"e_1_2_7_53_2","first-page":"1904","article-title":"Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus\u201012 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes","volume":"48","author":"Reddel R.R.","year":"1988","journal-title":"Cancer Res."},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.4.373"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-0436.1996.6040251.x"},{"key":"e_1_2_7_56_2","first-page":"833","article-title":"Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor\u2010\u03b3 in human teratocarcinomas","volume":"9","author":"Moasser M. M.","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_7_57_2","first-page":"1537","article-title":"Overexpression of the retinoic acid receptor\u2010\u03b3 directly induces terminal differentiation of human embryonal carcinoma cells","volume":"10","author":"Moasser M.M.","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201876"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.22013"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.2907"},{"key":"e_1_2_7_61_2","first-page":"2470","article-title":"Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development","volume":"59","author":"Lonardo F.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_7_62_2","first-page":"1365","article-title":"Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development","volume":"55","author":"Rusch V.","year":"1995","journal-title":"Cancer Res."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb02724.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb02724.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb02724.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T12:15:17Z","timestamp":1696767317000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb02724.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb02724.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb02724.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}